• LAST PRICE
    4.6000
  • TODAY'S CHANGE (%)
    Trending Down-0.2200 (-4.5643%)
  • Bid / Lots
    4.5900/ 8
  • Ask / Lots
    4.7800/ 2
  • Open / Previous Close
    4.7900 / 4.8200
  • Day Range
    Low 4.5800
    High 4.8700
  • 52 Week Range
    Low 4.5800
    High 12.6100
  • Volume
    107,894
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 4.82
TimeVolumeACIU
09:32 ET62134.78
09:33 ET12794.72
09:35 ET1004.72
09:39 ET2004.7
09:42 ET2504.74
09:44 ET3004.768
09:46 ET1004.8
09:48 ET2004.82
09:50 ET2004.78
09:51 ET1004.7867
09:53 ET1004.81
09:57 ET1004.8
10:00 ET1004.82
10:02 ET4044.79
10:08 ET1434.8
10:11 ET1004.82
10:13 ET1004.85
10:18 ET5034.87
10:20 ET10934.85
10:26 ET3434.83
10:29 ET10004.8236
10:33 ET1004.82
10:36 ET4004.79
10:38 ET1004.77
10:40 ET5004.71
10:45 ET4064.72
10:47 ET1004.73
10:49 ET11704.74
10:51 ET4004.72
10:56 ET1004.72
11:00 ET12004.71
11:02 ET12004.685
11:03 ET2004.699
11:05 ET1504.685
11:09 ET1004.685
11:12 ET1004.67
11:14 ET4004.68
11:18 ET2004.7
11:21 ET7004.6727
11:23 ET4004.665
11:25 ET12004.63
11:27 ET5004.62
11:30 ET1004.62
11:32 ET9004.65
11:38 ET5294.66
11:41 ET1004.68
11:43 ET5004.67
11:45 ET1004.66
11:48 ET1004.66
11:50 ET2004.66
11:52 ET17004.66
11:54 ET3004.66
11:57 ET1004.65
11:59 ET2004.64
12:01 ET1004.64
12:03 ET6004.65
12:06 ET1004.64
12:08 ET1004.64
12:10 ET1004.64
12:12 ET1004.64
12:14 ET4004.65
12:15 ET2004.65
12:17 ET1004.65
12:19 ET1004.65
12:26 ET5004.66
12:28 ET2084.66
12:33 ET16014.66
12:35 ET5254.6501
12:37 ET1614.669
12:39 ET1004.66
12:44 ET1004.66
12:46 ET1004.66
12:50 ET1004.665
12:51 ET1004.665
12:57 ET1004.67
01:00 ET10404.65
01:02 ET19774.62
01:09 ET1084.63
01:11 ET1004.64
01:15 ET3004.62
01:18 ET3504.63
01:22 ET4004.63
01:24 ET1004.63
01:27 ET2004.63
01:31 ET2004.63
01:38 ET10754.64
01:42 ET1184.645
01:49 ET2004.66
01:51 ET2004.645
01:56 ET1004.64
01:58 ET1214.66
02:00 ET1004.66
02:05 ET9224.66
02:07 ET5444.67
02:12 ET1004.68
02:14 ET4924.6629
02:16 ET1004.68
02:18 ET1004.68
02:20 ET7004.66
02:23 ET4004.65
02:30 ET1004.65
02:32 ET2004.66
02:34 ET2004.66
02:41 ET1004.668
02:45 ET1004.67
02:48 ET6354.67
02:50 ET1004.68
02:52 ET3004.69
02:54 ET1004.7
02:56 ET2384.7
02:59 ET1004.75
03:01 ET13004.68
03:03 ET3004.685
03:06 ET7114.66
03:14 ET1004.66
03:15 ET5004.65
03:17 ET2154.63
03:19 ET1004.64
03:24 ET10094.64
03:26 ET2584.65
03:32 ET6004.67
03:35 ET12954.66
03:37 ET46524.62
03:39 ET10314.62
03:42 ET1004.62
03:44 ET3004.62
03:46 ET29314.62
03:48 ET3434.62
03:50 ET8264.63
03:51 ET1004.62
03:53 ET18074.62
03:55 ET134384.585
03:57 ET23604.59
04:00 ET54024.6
Data delayed at least 15 minutes.

Dec 20, 2021

0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesACIU
AC Immune SA
349.0M
-4.3x
---
United StatesDTIL
Precision BioSciences Inc
361.0M
-8.7x
---
United StatesSELB
Selecta Biosciences Inc
323.1M
-5.3x
---
United StatesIKNA
Ikena Oncology Inc
408.3M
-6.1x
---
United StatesCRIS
Curis Inc
334.4M
-7.0x
---
United StatesSPRO
Spero Therapeutics Inc
426.7M
-4.7x
---
As of 2022-01-18

Company Information

AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative indications, such as Alzheimer's disease (AD). The Company's pipeline includes nine therapeutic product candidates with five in clinical trials, and three diagnostic candidates. Its lead product candidate is Crenezumab, a humanized and monoclonal anti-Abeta antibody for Alzheimer’s disease. It has collaborations with pharmaceutical companies, including Roche/Genentech, Eli Lilly, Biogen, Janssen Pharmaceuticals, Nestle Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.

Contact Information

Headquarters
EPFL Innovation Park, Building BLAUSANNE, Switzerland 1015
Phone
---
Fax
---

Executives

Independent Chairman of the Board
Douglas Williams
Chief Executive Officer, Co-Founder, Director
Andrea Pfeifer
Chief Financial Officer
Joerg Hornstein
Chief Technical Officer, Chief Operations Officer
Piergiorgio Donati
Chief Administrative Officer
Jean-Fabien Monin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$349.0M
Revenue (TTM)
$1.0M
Shares Outstanding
72.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.82
EPS
$-1.08
Book Value
$3.28
P/E Ratio
-4.3x
Price/Sales (TTM)
337.9
Price/Cash Flow (TTM)
---
Operating Margin
-8,017.80%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.